- A
- A
- A
Oral Chelation—The Strongest Natural Treatment for Your Heart, Arteries, Memory, and More—Has Just Become Even More Effective
Stay Healthy and Active With EDTA Chelation!
How much to take … how to know it's working … and how to further enhance the benefits
The dose of oral EDTA used in the studies cited above ranges from a low of 500 milligrams per day to a high of 4,000 milligrams per day, with the most common dose being around 1,000 to 2,000 milligrams. Unfortunately, the majority of oral chelation supplements available today make it nearly impossible for you to consume the recommended amount, without inordinate hassle … and stomachache. With some chelation supplements, you need to take up to 40 capsules per day to get the high-level dose of 4,000 milligrams of EDTA per day!
In addition, recent research has shown that, aside from EDTA, there are two natural compounds that also function as excellent chelation agents: garlic and malic acid.
Some oral chelation supplements do include garlic … but again, you have to take so much of the supplement that, needless to say, your daily dose of the garlic can become a bit on the high side, and a bit unpleasant. Of all the chelation formulations available today, only one provides enough EDTA per capsule—250 milligrams, or 0.25 grams—to maintain the recommended daily dose conveniently, and at minimum cost and hassle. This high-quality product, called CardioClear®, is quite simply the most effective and convenient oral chelation supplement you can find. In addition to providing the optimum dose of EDTA, malic acid, and garlic, CardioClear also includes parsley extract to absorb the garlic odor.
If you have a known CVD condition … you should see a qualified doctor and ask about IV chelation and oral chelation. If you have a condition but it is not serious enough to require medical attention now, then oral chelation alone is a good choice for maintenance and prevention. Finally, if you do not have a known condition, then CardioClear—the most powerful and reliable way to heal your arteries and support your entire circulatory system—can help keep you protected for life. SP
Other Benefits of EDTA Chelation*
-
Prevents cholesterol deposits
-
Heals calcified necrotic ulcers
-
Reduces blood cholesterol levels
-
Reduces intermittent claudication
-
Lowers high blood pressure
-
Improves vision in diabetic retinopathy
-
Avoids by-pass surgery
-
Decreases macular degeneration
-
Avoids angioplasty
-
Dissolves small cataracts
-
Reserves digitalis toxicity
-
Eliminates heavy metal toxicity
-
Removes calcium from atherosclerotic plaques
-
Makes arterial walls more flexible
-
Dissolves intra-arterial blood clots
-
Prevents osteoarthritis
-
Normalizes cardiac arrhythmias
-
Reduces rheumatoid arthritis symptoms
-
Has an anti-aging effect
-
Lowers diabetics' insulin needs
-
Reduces excessive heart contractions
-
Reduces Alzheimer-like symptoms
-
Increases intracellular potassium
-
Reverses senility
-
Reduces heart irritability
-
Reduces stroke/heart attack after-effects
-
Improves heart function
-
Prevents cancer
-
Removes mineral and drug deposits
-
Improves memory
-
Dissolves kidney stones
-
Reverses diabetic gangrene
-
Reduces serum iron levels
-
Restores impaired vision
-
Reduces heart valve calcification
- Reduces varicose veins
To find a doctor qualified …
to provide you with IV chelation treatments, contact the American College for Advancement in Medicine (ACAM) at:ACAM
23121 Verdugo Dr., Ste. 204
Laguna Hills, CA 92653
800 532 3688
http://www.acam.org
EDTA Chelation therapy appears to be extremely safe, but as with almost any drug or supplement, there are potential adverse effects of EDTA chelation. One danger is nephrotoxicity (kidney damage). This is dependent on the dose, the rate of infusion, the patient's kidney function, and the patient's body burden of toxic heavy metals. Kidney damage was not uncommon in the early days of chelation therapy, when doses of EDTA in the range of 5-10 grams per day were used, and treatments were administered as often as 5 days per week.
Kidney damage can be easily prevented, however, by carefully adjusting the frequency, dose and rate in which the EDTA is administered. In addition, judicious administration of EDTA over prolonged periods (three to six months and longer) actually improves kidney function.
Other potential adverse effects include hypocalcemia (excessively low blood levels of calcium) due to EDTA's binding excessively with calcium in the blood, hypoglycemia (low blood sugar), believed to be due to accompanying hypocalcemia, and phlebitis (inflammation of the vein), usually due to improperly prepared solutions. Rarely reported side effects include chills and fever following infusion, acerbation of congestive heart failure due to fluid overload, fatigue (usually due to hypoglycemia or hypocalcemia), seizures, arrhythmias, or rash. The risk of incurring any of the above adverse effects has further been greatly reduced by the recent finding of Drs. Grant Born and Tammy Geurkink23 that even greater benefit can be obtained by most patients who are treated with only 1.5 grams of EDTA per treatment, rather than with the standard dose of three grams. (But this refers to the IV infusion of EDTA, not to be confused with dosages for oral use, which are in the range of 500 mg to 4,000 mg per day.)
Editor's Note:
The natural health solutions described in this article are available through many on-line retailers including those listed below. By clicking these links you help support the important alternative health research we provide.
Visit www.amazon.com – a great way to find competitive deals on supplements offered by many different manufacturers.
Visit www.hfn-usa.com – when commitment to quality and freshness is important, this factory direct solution is preferred by many of our readers.
This article is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a physician before embarking on a dietary supplement program.
References
-
EDTA Chelation: A Misunderstood Therapy for Atherosclerosis and Other Diseases, by Ward Dean, MD, August 1997, VRP Library, http://www.vrp.com.
-
Parisi AF, Folland ED, Hartigan PA. Comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-16.
-
Edmunds LH, Stephenson LW, Edie RN, Ratcliffe MB. Open-heart surgery in octogenarians. N Engl J Med 1988; 319:131-136.
-
CASS Principal Investigators and the Associates. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery: Survival data. Circulation. 1983; 68: 939-950.
-
Arom KV, Cohen DE, Strobl FT. Effect of intraoperative intervention on neurological outcome based on electroencephalographic monitoring during cardiopulmonary bypass.Ann Thorac Surg. 1988; 48:476-483.
-
Arom KV, Cohen DE, Strobl FT. Effect of intraoperative intervention on neurological outcome based on electroencephalographic monitoring during cardiopulmonary bypass.Ann Thorac Surg. 1988; 48:476-483.
-
Center for Disease control website: http://www.cdc.gov
-
Cranton, Elmer. Bypassing Bypass (2d Ed). Medex Publishers, Trout Dale, VA 24378-0044, 1992.
-
EDTA Chelation: A Misunderstood Therapy for Atherosclerosis and Other Diseases, by Ward Dean, MD, August 1997, VRP Library.http://www.vrp.com.
-
Harman, D. The biologic clock: The mitochondria? J Am Geriatr Soc, 1972, 20: 145-147.
-
EDTA Chelation: A Misunderstood Therapy for Atherosclerosis and Other Diseases, by Ward Dean, MD, August 1997, VRP Library,http://www.vrp.com.
-
Clarke NE, Clarke CN, Mosher RE. Treatment of angina pectoris with disodium ethelyne diamene tetraacetic acid. Am J Med Sci. 1956: December: 654-666.
-
Meltzer LE, Ural E, Kitchell JR. The treatment of coronary artery heart disease with disodium EDTA. In: Seven M, ed. Metal-Binding in Medicine, Philadelphia: JB Lippincott: 1960.
-
These papers, The correlation between EDTA Chelation Therapy and improvement in cardiovascular function: A Meta-Analysis, and EDTA Chelation Treatment for vascular disease: A Meta-Analysis using unpublished data, both by L.T. Chappell and J.P. Stahl, were published in the Journal of Advancement in Medicine in 1993 and 1994.
-
Hancke, C. and Flytlie, K, Benefits of EDTA Chelation Therapy in Arteriosclerosis: A retrospective study of 470 patients, Journal of Advancement in Medicine, 1993, 6:3, 161-171.
-
Olszewer E, Carter JP. EDTA chelation therapy in chronic degenerative disease. Med Hypotheses. 1988; 27:41-49.
-
Olszewer E, Sabbag FC, Carter JP. A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease. J Natl Med Assoc 1990; 82:173-174.
-
Hancke C, Flytie K. Benefits of EDTA chelation therapy on arteriosclerosis. J Adv Med. 1993; 6:161-172.
-
Chappell LT, Janson M. EDTA chelation therapy in the treatment of vascular disease. J Cardiovasc Nurs. 1996; 10:78-86.
-
Perry, H. Mitchell, Schroeder, Henry A. Depression of cholesterol levels in human plasma following ethylenediamine tetracetate and hydralazine. J Chronic Diseases, 1955, 2: 5, 520-532.
-
Schroeder, Henry A. A practical method for the reduction of plasma cholesterol in man. J Chronic Diseases, 1956, 4: 461-468.
-
Perry, Jr., and Camel, G., Some effects of CaNa2EDTA on plasma cholesterol and urinary zinc in man, in: Metal Binding in Medicine, by Marvin J. Seven and L. Audrey Johnson (eds), 1960, J.B. Lippincott Company, Philadelphia, 209-215.
-
Born, G.R., and Geurkink, T.L. Improved peripheral vascular function with low dose intravenous ethylene diamine tetraacetic acid (EDTA). Townsend Letter for Doctors. July, 1994, # 132, 722-726.